Shao, S., Zhao, C., Liu, H., Wang, C., Zhu, J., Wei, D., Jiang, Y. (2025). Daratumumab and venetoclax-based combined regimen for relapsed/refractory T-lymphoblastic leukemia/lymphoma. Blood. https://doi.org/10.1182/blood-2025-1568